1. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990; 9: 587–593.
2. Soto PF, Jia CX, Carter YM, et al. Effect of improved myocardial protection on edema and diastolic properties of the rat left ventricle during acute allograft rejection. J Heart Lung Transplant 1998; 17: 608–616.
3. Herskowitz A, Soule LM, Ueda K, et al. Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients. J Heart Transplant 1987; 6: 127.
4. Fishbein MC, Bell G, Lones MA, et al. Grade 2 cellular heart rejection: does it exist? J Heart Lung Transplant 1994; 13: 1051–1057.
5. Marboe CC, Schierman SW, Rose EA, et al. In situ lymphocyte typing in cardiac allograft rejection. Transplant Proc 1984; 16: 1598–1599.